Tadalafil Tablet
Product Images NDC 71610-896

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 71610-896). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0896 06)

FDA Label Image

Aphena (Aphena)

FDA Label Image

Figure8 (Tadalafil Fig8)

Figure8 (Tadalafil Fig8)
This appears to be a comparison between the change in total score from baseline in patients taking Tadalafil 5mg versus a placebo. The data suggests a statistically significant difference (p<0.01) between the two groups. The duration of treatment in weeks is also mentioned but specific values are missing.*
FDA Label Image

Figure1 (Tadalafil Figure1)

FDA Label Image

Figure2 (Tadalafil Figure2)

FDA Label Image

Figure3 (Tadalafil Figure3)

FDA Label Image

Figure4 (Tadalafil Figure4)

FDA Label Image

Figure5 (Tadalafil Figure5)

FDA Label Image

Figure6 (Tadalafil Figure6)

FDA Label Image

Figure7 (Tadalafil Figure7)

FDA Label Image

Structure (Tadalafil Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.